TP53 Gene Mutation, an Unfavorable Prognostic Factor for Malignant Lymphomas in Autoimmune Diseases

Publisher： Karger

E-ISSN： 1423-0232|69|2|175-183

ISSN： 0030-2414

Source： Oncology, Vol.69, Iss.2, 2005-09, pp. : 175-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Malignant triton tumor in a patient with Li‐Fraumeni syndrome and a novel TP53 mutation

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 49, Iss. 7, 2007-12 ,pp. : 1000-1004

John Wiley & Sons Inc

Access to resources Recommend Favorite

TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 1, 2015-10 ,pp. : 91-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 7-1048, Iss. 1, 2015-10 ,pp. : 91-99

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers

By  

CANCER, Vol. 120, Iss. 7, 2014-04 ,pp. : 1068-1075

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of HPV RNA transcription, immune response‐related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 12, 2015-12 ,pp. : 2846-2857

John Wiley & Sons Inc

Access to resources Recommend Favorite